DUBLIN--(BUSINESS WIRE)--The "Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.
The extra corporeal membrane oxygenation (ECMO) system market in Europe is expected to surge at a CAGR of 4.63% over the projected period 2019-2028.
The United Kingdom is home to several adults and pediatric ECMO centers. The system is available in 15 different cities spread across the country. Glenfield Hospital is UK-based healthcare, which is one of the busiest extra corporeal membrane oxygenation (ECMO) centers in the world. It is reported that, in 2017, about 66,341 deaths in the country were caused due to coronary heart disease. These deaths can be limited with the use of ECMO systems. The rising incidence of cardiovascular diseases and the growing adoption of ECMO systems is anticipated to drive the studied market in the UK.
In Germany, the use of ECMO has been increasing rapidly for respiratory and cardiac support. The prevalence of cardiovascular diseases in the country continue to expand and are one of the leading cause of deaths. As per the WHO (World Health Organization), approximately 100,000 deaths were caused in 2015 due to ischemic heart disease in the country. These factors are expected to fuel its extra corporeal membrane oxygenation (ECMO) system market.
Key Topics Covered:
1. Europe Extra Corporeal Membrane Oxygenation (Ecmo) System Market - Summary
2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.3. Impact of Covid-19 on ECMO System Market
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Key Insights
2.7. Market Drivers
2.7.1. Rising Popularity of ECMO Technology
2.7.2. Increasing Prevalence of Chronic Disorders
2.8. Market Restraints
2.8.1. Significant Cost of ECMO Systems
2.8.2. Existence of Alternative Techniques
2.9. Market Opportunities
2.9.1. Growing Awareness Regarding Applications of ECMO Systems
2.9.2. Advancement in Technology
2.10. Market Challenges
2.10.1. Lack of Specialized Skills for Operation
2.10.2. Risks Associated With ECMO Procedures
3. Extra Corporeal Membrane Oxygenation (Ecmo) System Market Outlook - by Application
3.1. Respiratory
3.2. Cardiac
3.3. Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
4. Extra Corporeal Membrane Oxygenation (Ecmo) System Market Outlook - by Modality
4.1. Veno-Venous
4.2. Veno-Arterial
4.3. Other Modalities
5. Extra Corporeal Membrane Oxygenation (Ecmo) System Market - Europe
5.1. United Kingdom
5.2. Germany
5.3. France
5.4. Italy
5.5. Russia
5.6. Spain
5.7. Rest of Europe
6. Company Profiles
6.1. Hemovent GmbH
6.2. Livanova plc
6.3. Microport Scientific Corporation
6.4. Terumo Medical Corporation
6.5. Elsius Biomedical Inc
6.6. Abbott Laboratories
6.7. Alung Technologies Inc
6.8. Eurosets
6.9. Spectrum Medical
6.10. Xenios AG (Fresenius SE & Co KGAA)
6.11. Medtronic plc
6.12. Getinge Ab
6.13. Nipro Corporation
6.14. Origen Biomedical Inc
For more information about this report visit https://www.researchandmarkets.com/r/n4lvgt
